Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Euros

Status: Active, not recruiting

Conditions: Hip Fractures; Hip Arthropathy; Hip Osteoarthritis; Hip Dysplasia; Hip Necrosis; Hip Arthritis

Treatments: Device: Hip arthroplasty

Study type: Observational

Funder types: Industry

Identifiers

NCT05142462

2021-A01650-41 (Other Identifier)

EC-310-01-01

Details and patient eligibility

About

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

Full description

Post market observational study. This study is retropective and prospective, non comparative.

Enrollment: 120 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who received EUROSCUP Fixe.
• Patient informed of its participation to the study
• Patient aged between 18 and 80 years old (<80).

Exclusion criteria

• Patient presenting a contraindication to EUROSCUP Fixe implantation.
• Patient who refused to participate to the study
• Vulnerable subjects

Trial design

120 participants in 1 patient group

EUROSCUP Fixe

Description:

120 patients who received EUROSCUP Fixe

Treatment:

Device: Hip arthroplasty